The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis
Conclusion: Our meta-analysis suggested a better treatment response rate and lower risk of colectomy in the first, second and third year, with IFX, compared with CYS in steroid-refractory UC patients. There was no significant difference among IFX and calcineurin inhibitors in AE, SAE, and mortality.
Source: The Saudi Journal of Gastroenterology - Category: Gastroenterology Authors: Heng-Nan Zhao Min Jiang Ming-Jun Sun Cong Dai Source Type: research
More News: Colectomy | Databases & Libraries | Gastroenterology | Inflammatory Bowel Disease | Middle East Health | Prograf | Remicade | Restasis | Saudi Arabia Health | Study | Tacrolimus | Ulcerative Colitis